News | November 15, 2023
IOL Chemicals and Pharmaceuticals Q2 PAT jumps 141% to Rs. 37.8 Cr
EBITDA for Q2 FY24 at Rs. 71.2 crore as compared to Rs. 79.9 crore QoQ
EBITDA for Q2 FY24 at Rs. 71.2 crore as compared to Rs. 79.9 crore QoQ
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
IOL Chemicals and Pharmaceuticals has reported total income of Rs. 570.24 crores during the period ended June 30, 2023
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
The 'A+' rating reflects IOL's robust business model, diversified product portfolio
The certification issued by the EDQM verifies the compliance of pharmaceutical substances
Super-Bond is made up of a polymerization initiator, a liquid and a polymer powder
Net profit for FY23 at Rs. 140 crore as compared to Rs. 166 crore in FY22
The combination will support clients in getting their end-to-end discovery and development programs delivered.
Calibre will enhance the pace of new product development and the breadth of its Custom Development and Manufacturing (CDMO) Service offerings.
Subscribe To Our Newsletter & Stay Updated
